Please provide your email address to receive an email when new articles are posted on . The FDA has granted breakthrough device designation to Linus Biotechnology Inc. for a diagnostic aid that may ...

Atrial septal defect closure techniques have evolved considerably over recent decades. Traditional surgical repair, once the mainstay of treatment for congenital heart anomalies, has gradually been ...

LONDON--(BUSINESS WIRE)--The global heart defect closure devices market research report by Technavio predicts the market to post a CAGR of more than 29% during the period 2019-2023. A key driver for ...